Platelet-activating factor. A putative mediator in central nervous system injury?

Area of Science:

• Neuroscience
• Biochemistry
• Pathophysiology

Background:

• Platelet-activating factor (PAF) is a potent lipid autacoid produced by various cell types, including cerebellar granule cells.
• PAF receptors are present in brain tissue, and their activation can increase intracellular calcium in neuronal cell lines.
• PAF influences cerebral vessels and metabolism, though direct effects on brain microvessels are uncertain.

Purpose of the Study:

• To review and analyze the evidence supporting the role of PAF in modulating brain function.
• To investigate the involvement of PAF in pathophysiological processes of brain ischemia and trauma.
• To evaluate the potential of PAF antagonists in mitigating brain injury.

Main Methods:

• Review of existing literature on PAF production, receptors, and actions in the central nervous system.
• Analysis of studies investigating PAF's role in experimental models of neurotrauma and stroke.
• Examination of data from studies utilizing PAF antagonists to assess their therapeutic effects.

Main Results:

• Excessive PAF production is implicated in pathological states like neurotrauma and stroke (e.g., spinal cord ischemia, focal brain injury).
• PAF antagonists have demonstrated efficacy in preventing or reversing critical aspects of brain injury.
• These beneficial effects include mitigating hypoperfusion, reperfusion injury, edema, inflammation, neurological deficits, and promoting neuronal salvage.

Conclusions:

• PAF is a significant modulator of brain function and plays a critical role in the pathophysiology of brain ischemia and trauma.
• Targeting PAF with antagonists represents a promising therapeutic strategy for managing neurological injuries.
• Further research is warranted to fully elucidate PAF's complex role in the nervous system.